Edition:
India

People: Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

2,070JPY
21 Jul 2019
Change (% chg)

¥-7 (-0.34%)
Prev Close
¥2,077
Open
¥2,056
Day's High
¥2,080
Day's Low
¥2,045
Volume
84,700
Avg. Vol
104,662
52-wk High
¥2,677
52-wk Low
¥1,790

Kato, Hiroki 

Mr. Hiroki Kato has been serving as Director of Pharmaceutical Sales and Director in Zeria Pharmaceutical Co., Ltd. since February 5, 2019. He joined the Company in April 1988. His previous titles include Director of Medical Development, Director of 3rd Clinical Development and Director of 1st Clinical Development in the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --